<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2025-31-38-44</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-4745</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Эхокардиографические параметры ремоделирования левого желудочка у пациентов со сниженной фракцией выброса до и после применения различных видов реваскуляризации миокарда</article-title><trans-title-group xml:lang="en"><trans-title>Echocardiographic parameters of left ventricle remodeling in patients with reduced ejection fraction before and after various types of myocardial revascularization</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреева</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreeva</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андреева Алина Евгеньевна – заведующая отделением функциональной диагностики, асс. кафедры функциональной диагностики</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Andreeva Alina Evgenievna – chief of theDepartment of Functional Diagnostics</p><p>St. Petersburg</p></bio><email xlink:type="simple">alina.andreeva@szgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9770-472X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Найден</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Naiden</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Найден Татьяна Викторовна – к.м.н., доц. кафедры функциональной диагностики</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Nayden Tatyana Viktorovna – PhD, Associate Professor, Department of Functional Diagnostics </p><p>St. Petersburg</p></bio><email xlink:type="simple">tatianan86@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7300-1942</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бартош-Зеленая</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Bartosh-Zelenaya</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бартош-Зеленая Светлана Юрьевна – д.м.н., проф., проф. кафедры функциональной диагностики</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Bartosh-Zelenaya Svetlana Yuryevna – MD, PhD, prof., prof. of the Department of Functional Diagnostics</p><p>St. Petersburg</p></bio><email xlink:type="simple">s.bartosh.spb@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9444-159X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Берштейн</surname><given-names>Л. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Berstein</surname><given-names>L. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Берштейн Леонид Львович– д.м.н., проф., проф. кафедры кардиологии  </p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Berstein Leonid Lvovich – MD, PhD, prof., prof. of the Department of Cardiology</p><p>St. Petersburg</p></bio><email xlink:type="simple">l_berstein@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Северо-Западный государственный медицинский университет им. И.И. Мечникова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mechnikov North-Western State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>06</day><month>12</month><year>2025</year></pub-date><volume>0</volume><issue>31</issue><issue-title>Современная функциональная диагностика (4)</issue-title><fpage>38</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Андреева А.Е., Найден Т.В., Бартош-Зеленая С.Ю., Берштейн Л.Л., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Андреева А.Е., Найден Т.В., Бартош-Зеленая С.Ю., Берштейн Л.Л.</copyright-holder><copyright-holder xml:lang="en">Andreeva A.E., Naiden T.V., Bartosh-Zelenaya S.Y., Berstein L.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/4745">https://www.med-alphabet.com/jour/article/view/4745</self-uri><abstract><p>Ремоделирование миокарда левого желудочка (ЛЖ) после перенесенного инфаркта миокарда (ИМ) в большинстве случаев ассоциировано с неблагоприятным прогнозом. В ряде случаев, помимо оптимальной медикаментозной терапии, возможно применение хирургических методов реваскуляризации с целью остановить или замедлить процесс ремоделирования. Целью настоящего исследования было выявить структурные и функциональные параметры ремоделирования сердца, влияющие на прогноз и выживаемость пациентов после коронарной реваскуляризации, производимой тем или иным методом, сравнить эти параметры в группах пациентов, перенесших аорто-коронарное шунтирование и стентирование коронарных артерий. Было обследовано 104 пациента с ИБС и сниженной фракцией выброса (ФВ) до, в короткие сроки (5–10 дней) и через 6–12 мес. после реваскуляризации миокарда. Средний возраст больных составил 58 [54; 66] лет, среди них 85% мужчин, 15% женщин. Прооперировано 82% пациентов, из них у 62 (59,6%) человек выполнено аортокоронарное шунтирование (АКШ), стентирование коронарных артерий (КА) – у 23 (22,1%) пациентов. Полная ревакуляризация достигнута в 24 (28,2%) случаях. Помимо стандартных линейных и объемных показателей рассчитывали индекс сферичности в диастолу (КДР/ продольный размер ЛЖ в диастолу) и систолу (КСР/ продольный размер ЛЖ в систолу), а также интегральный систолический индекс ремоделирования (ИСИР), как отношение ФВ к диастолическому индексу сферичности ЛЖ в единицах. Следовательно, к параметрам ремоделирования, представляющим интерес для оценки результатов реваскуляризации относятся ИКДО, ФВ ЛЖ, диастолический индекс сферичности и интегральный систолический индекс ремоделирования. У пациентов, которым было выполнено АКШ, данные параметры отражали меньшую степень ремоделирования левого желудочка: меньше индекс конечно-диастолического объема левого желудочка, диастолический индекс сферичности и интегральный систолический индекс ремоделирования, выше фракция выброса левого желудочка.</p></abstract><trans-abstract xml:lang="en"><p>Left ventricular (LV) myocardial remodeling after myocardial infarction (MI) is associated with worse prognosis in most cases. In some cases, inaddition to optimal drug therapy, surgical revascularization can be used to stop or slow down the remodeling process. The aim of this study was to identify structural and functional parameters of cardiac remodeling that affect the prognosis and survival of patients after coronary revascularization performed by anyone method, and to compare these parameters in groups of patients who underwent coronary artery bypass grafting (CABG) and coronary artery stenting (CAS). A total of 104 patients with coronary artery disease and reduced ejection fraction (EF) were examined before, shortly after (5–10 days), and 6–12 months after myocardial revascularization. The average age of patients was 58 [54; 66] years old, including 85% men and 15% women. 82% of patients were operated on, of which 62 (59.6%) patients underwent CABG and 23 (22.1%) patients underwent CAS. Complete revascularization was achieved in 24 (28.2%) cases. In addition to the standard linear and volumetric dimensions, the sphericity index was calculated in diastole (end-diastolic diameter, EDD/longitudinal dimension of the LV in diastole) and systole (end-sistolic diameter, ESD/longitudinal dimension of the LV in systole), as well as the integral systolic remodeling index (ISRI), as the ratio of EF to the diastolic sphericity index of the LV in units. The remodeling parameters of interest for assessing the results of revascularization include EDVI, LVEF, diastolic sphericity index and integral systolic remodeling index. In patients who underwent CABG, these parameters reflected a lower degree of left ventricular remodeling: lower left ventricular end-diastolic volume index, diastolic sphericity index, and integral systolic remodeling index, and higher left ventricular ejection fraction.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сердечная недостаточность со сниженной фракцией выброса</kwd><kwd>ремоделирование левого желудочка</kwd><kwd>индекс сферичности</kwd><kwd>интегральный систолический индекс ремоделирование</kwd><kwd>реваскуляризации миокарда</kwd></kwd-group><kwd-group xml:lang="en"><kwd>heart failure with reduced ejection fraction</kwd><kwd>left ventricular remodeling</kwd><kwd>sphericity index</kwd><kwd>integral systolic remodeling index</kwd><kwd>myocardial revascularization</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др. «Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр) Утверждены на Конгрессе ОССН 7 декабря 2012 года, на Правлении ОССН 31 марта 2013 и Конгрессе РКО 25 сентября 2013 года» Журнал Сердечная Недостаточность. Том 14, № 7 (81), 2013 г. С. 379–472.</mixed-citation><mixed-citation xml:lang="en">Mareev V.Yu., Ageev F.T., Arutyunov G.P. et al. National guidelines of the OSSN, RKO and RNMOT for the diagnosis and treatment of CHF (fourth revision). Approved at the OSSN Congress on December 7, 2012, at the OSSN Board on March 31, 2013 and the RKO Congress on September 25, 2013. Journal of Heart Failure. Vol. 14, No. 7 (81), 2013. P. 379–472.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gheorghiade M., Sopko G., De Luca L. et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006. 12; 114(11): P. 1202–1213.</mixed-citation><mixed-citation xml:lang="en">Gheorghiade M., Sopko G., De Luca L. et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006. 12; 114(11): P. 1202–1213.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hobbs F.D., Roalfe A.K., Davis R.C. et al. Midlands Research Practices Consortium (MidReC) Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J. 2007. 28(9): P. 1128–1134.</mixed-citation><mixed-citation xml:lang="en">Hobbs F.D., Roalfe A.K., Davis R.C. et al. Midlands Research Practices Consortium (MidReC) Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J. 2007. 28(9): P. 1128–1134.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Konstam M.A., Kramer D.G., Patel A.R. et al. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011; 4(1): P. 98-108. doi: 10.1016/j.jcmg.2010.10.008. PMID: 21232712.</mixed-citation><mixed-citation xml:lang="en">Konstam M.A., Kramer D.G., Patel A.R. et al. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011; 4(1): P. 98-108. doi: 10.1016/j.jcmg.2010.10.008. PMID: 21232712.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Белов Ю.В., Вараксин В.А. Постинфарктное ремоделирование левого желудочка сердца. От концепции к хирургическому лечению. – М. :ДеНово, 2002. – 194 с.</mixed-citation><mixed-citation xml:lang="en">Belov Yu.V., Varaksin V.A. Postinfarction remodeling of the left ventricle of the heart. From concept to surgical treatment. – M.: DeNovo, 2002. – 194 p.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mann D.L. Mechanisms and models in heart failure: A combinatorial approach. Circulation. 1999; 100: P. 999–1008.</mixed-citation><mixed-citation xml:lang="en">Mann D.L. Mechanisms and models in heart failure: A combinatorial approach. Circulation. 1999; 100: P. 999–1008.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ciampi Q., Villari B. Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. Cardiovasc. Ultrasound. 2007; 5: P. 34. doi: 10.1186/1476-7120-5-34.</mixed-citation><mixed-citation xml:lang="en">Ciampi Q., Villari B. Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. Cardiovasc. Ultrasound. 2007; 5: P. 34. doi: 10.1186/1476-7120-5-34.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Нечесова Т.А., Коробко И.Ю., Кузнецова Н.И. Ремоделирование левого желудочка: патогенез и методы оценки Журнал «Медицинские новости». Архив № 11. 2008. С. 7–13.</mixed-citation><mixed-citation xml:lang="en">Nechesova T.A., Korobko I.Yu., Kuznetsova N.I. Left ventricular remodeling: pathogenesis and assessment methods. Journal «Medical News». Archive No. 11. 2008. P. 7–13.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Puymirat E., Simon T., Steg P.G. et al. USIK USIC 2000 Investigators; FAST MI Investigators. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012; 308: P. 998–1006</mixed-citation><mixed-citation xml:lang="en">Puymirat E., Simon T., Steg P.G. et al. USIK USIC 2000 Investigators; FAST MI Investigators. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012; 308: P. 998–1006</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wijns W., Kolh P., Danchin N. et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal, Volume 31, Issue 20, 1 October 2010, Pages 2501–2555, https://doi.org/10.1093/eurheartj/ehq277</mixed-citation><mixed-citation xml:lang="en">Wijns W., Kolh P., Danchin N. et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal, Volume 31, Issue 20, 1 October 2010, Pages 2501–2555, https://doi.org/10.1093/eurheartj/ehq277</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Topkara V.K., Cheema F.H., Kesavaramanujam S. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005; 112: P. 344–I-350.</mixed-citation><mixed-citation xml:lang="en">Topkara V.K., Cheema F.H., Kesavaramanujam S. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005; 112: P. 344–I-350.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lawton J.S., Tamis-Holland J.E., Bangalore S. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039.</mixed-citation><mixed-citation xml:lang="en">Lawton J.S., Tamis-Holland J.E., Bangalore S. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Petrie M.C., Jhund P.S., She L. et al. Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH trial (Surgical Treatment for Ischemic Heart Failure). Circulation. 2016;134: P. 1314–1324.</mixed-citation><mixed-citation xml:lang="en">Petrie M.C., Jhund P.S., She L. et al. Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH trial (Surgical Treatment for Ischemic Heart Failure). Circulation. 2016;134: P. 1314–1324.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Leancă S.A., Crişu D., Petriş A.O. et al. Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment. Life (Basel). 2022. 24; 12(8): P. 1111. doi: 10.3390/life12081111.</mixed-citation><mixed-citation xml:lang="en">Leancă S.A., Crişu D., Petriş A.O. et al. Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment. Life (Basel). 2022. 24; 12(8): P. 1111. doi: 10.3390/life12081111.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">McCartney P.J., Berry C. Redefining successful primary PCI. Eur. Heart J. Cardiovasc. Imaging. 2019; 20: P. 133–135. doi: 10.1093/ehjci/jey159.</mixed-citation><mixed-citation xml:lang="en">McCartney P.J., Berry C. Redefining successful primary PCI. Eur. Heart J. Cardiovasc. Imaging. 2019; 20: P. 133–135. doi: 10.1093/ehjci/jey159.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Grabka M., Kocierz-Woźnowska M., Wybraniec M. et al. Left ventricular reverse remodeling in patients with anterior wall ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention. PostepyKardiol. Interwencyjnej. 2018;14:373–382. doi: 10.5114/aic.2018.79867.</mixed-citation><mixed-citation xml:lang="en">Grabka M., Kocierz-Woźnowska M., Wybraniec M. et al. Left ventricular reverse remodeling in patients with anterior wall ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention. PostepyKardiol. Interwencyjnej. 2018;14:373–382. doi: 10.5114/aic.2018.79867.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Reindl M., Reinstadler S.J., Tiller C. et al. Prognosis-based definition of left ventricular remodeling after ST-elevation myocardial infarction. Eur. Radiol. 2019;29: P. 2330–2339. doi: 10.1007/s00330-018-5875-3.</mixed-citation><mixed-citation xml:lang="en">Reindl M., Reinstadler S.J., Tiller C. et al. Prognosis-based definition of left ventricular remodeling after ST-elevation myocardial infarction. Eur. Radiol. 2019;29: P. 2330–2339. doi: 10.1007/s00330-018-5875-3.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Vrints C., Andreotti F., Koskinas K.C. et al. ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.</mixed-citation><mixed-citation xml:lang="en">Vrints C., Andreotti F., Koskinas K.C. et al. ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kunadian V., Zaman A., Qiu W. Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies. Eur J Heart Fail 2011. 13: P. 773–784.</mixed-citation><mixed-citation xml:lang="en">Kunadian V., Zaman A., Qiu W. Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies. Eur J Heart Fail 2011. 13: P. 773–784.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Мареев В.Ю., Фомин И.В., Агеев Ф.Т., и др. Клинические рекомендации ОССН – РКО – РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ХДСН). Диагностика, профилактика и лечение. Кардиология. 2018; 58(6S): с. 8–158. https://doi.org/10.18087/cardio.2475.</mixed-citation><mixed-citation xml:lang="en">Mareev V.Yu., Fomin I.V., Ageev F.T. et al. Clinical guidelines of the Russian Society of Cardiology – Russian Society of Cardiology – Russian Society of Cardiology. Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnostics, prevention and treatment. Cardiology. 2018; 58(6S): P. 8–158. https://doi.org/10.18087/cardio.2475.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yamazaki S., Numata S., Yaku H. The Ultimate Goals of Surgical Ventricular Reconstruction: Volume, Shape and Viability. Journal of Coronary Artery Disease. 2019; 25: 34 – 38.</mixed-citation><mixed-citation xml:lang="en">Yamazaki S., Numata S., Yaku H. The Ultimate Goals of Surgical Ventricular Reconstruction: Volume, Shape and Viability. Journal of Coronary Artery Disease. 2019; 25: 34 – 38.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mauger C.A., Gilbert K., Suinesiaputra A. et al. Multi-Ethnic Study of Atherosclerosis: Relationship between Left Ventricular Shape at Cardiac MRI and 10-year Outcomes. Radiology. 2023 Feb;306(2):e220122. doi: 10.1148/radiol.220122. Epub 2022 Sep 20. PMID: 36125376; PMCID: PMC9870985.</mixed-citation><mixed-citation xml:lang="en">Mauger C.A., Gilbert K., Suinesiaputra A. et al. Multi-Ethnic Study of Atherosclerosis: Relationship between Left Ventricular Shape at Cardiac MRI and 10-year Outcomes. Radiology. 2023 Feb;306(2):e220122. doi: 10.1148/radiol.220122. Epub 2022 Sep 20. PMID: 36125376; PMCID: PMC9870985.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wu P., Zhao Y. Guo X. Prognostic Value of Resting Left Ventricular Sphericity Indexes in Coronary Artery Disease With Preserved Ejection Fraction. Journal of American Heart Association. 2024; 13:e032169. DOI: 10.1161/JAHA.123.032169.</mixed-citation><mixed-citation xml:lang="en">Wu P., Zhao Y. Guo X. Prognostic Value of Resting Left Ventricular Sphericity Indexes in Coronary Artery Disease With Preserved Ejection Fraction. Journal of American Heart Association. 2024; 13:e032169. DOI: 10.1161/JAHA.123.032169.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Arnold JR, Kanagala P, Budgeon CA, Jerosch-Herold M. et al. Prevalence and prognostic significance of microvascular dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol Img. 2022; 15:1001– 1011. doi: 10.1016/j.jcmg.2021.11.022.</mixed-citation><mixed-citation xml:lang="en">Arnold JR, Kanagala P, Budgeon CA, Jerosch-Herold M. et al. Prevalence and prognostic significance of microvascular dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol Img. 2022; 15:1001– 1011. doi: 10.1016/j.jcmg.2021.11.022.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pagliaro BR, Cannata F, Stefanini GG, Bolognese L. Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev. 2020; 25:53–65. doi: 10.1007/s10741-019-09831-z</mixed-citation><mixed-citation xml:lang="en">Pagliaro BR, Cannata F, Stefanini GG, Bolognese L. Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev. 2020; 25:53–65. doi: 10.1007/s10741-019-09831-z</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
